We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+263.17%
AUM
$3.93B
AUM Growth
-$48.7M
Cap. Flow
-$550M
Cap. Flow %
-13.99%
Top 10 Hldgs %
10.03%
Holding
559
New
64
Increased
137
Reduced
176
Closed
35

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$23.8M
2
PAYC icon
Paycom
PAYC
+$18.7M
3
BURL icon
Burlington
BURL
+$15.4M
4
GWRE icon
Guidewire Software
GWRE
+$11M
5
CLC
Clarcor
CLC
+$10.8M

Top Sells

Rank Stock Value
1
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$20.8M
2
HCC
HCC INSURANCES HOLDINGS INC
HCC
+$19.6M
3
IMPV
Imperva, Inc.
IMPV
+$18.4M
4
DXCM icon
DexCom
DXCM
+$17.1M
5
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 15.16%
2 Industrials 12.15%
3 Healthcare 10.73%
4 Consumer Discretionary 9.95%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRC
276
DELISTED
California Resources Corporation
CRC
$2.22M 0.06%
36,821
+30,223
+458% +$2.44M
SLM icon
277
SLM Corp
SLM
$5.24B
$2.2M 0.06%
222,750
-200
-0.1% -$2.02K
TMUSP
278
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
$2.1M 0.05%
30,673
-5,925
-16% -$384K
CVX icon
279
Chevron
CVX
$379B
$2.09M 0.05%
21,671
+25
+0.1% +$2.63K
CLNY
280
DELISTED
Colony Capital, Inc.
CLNY
$2.04M 0.05%
+90,300
New +$2.29M
HCR
281
DELISTED
Hi-Crush Inc. Common Stock
HCR
$1.95M 0.05%
63,500
-300
-0.5% -$9.86K
KDNY
282
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.95M 0.05%
+12,838
New +$2.12M
LEG icon
283
Leggett & Platt
LEG
$1.43B
$1.82M 0.05%
+37,465
New +$1.75M
AA icon
284
Alcoa
AA
$12.4B
$1.74M 0.04%
65,079
-66,616
-51% -$2.06M
LOPE icon
285
Grand Canyon Education
LOPE
$3.93B
$1.7M 0.04%
40,000
– –
DOC
286
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.67M 0.04%
108,650
-9,375
-8% -$155K
HUM icon
287
Humana
HUM
$43.5B
$1.53M 0.04%
+8,000
New +$1.48M
KYNB
288
Kyntra Bio
KYNB
$28M
$1.53M 0.04%
2,600
+1,000
+63% +$582K
GILD icon
289
Gilead Sciences
GILD
$168B
$1.52M 0.04%
13,000
– –
ROP icon
290
Roper Technologies
ROP
$38.8B
$1.49M 0.04%
8,622
-652
-7% -$113K
PPL
291
PPL Corp
PPL
$26.5B
$1.48M 0.04%
50,229
-13,267
-21% -$415K
WELL.PRI
292
DELISTED
Welltower Inc.
WELL.PRI
$1.43M 0.04%
23,897
-1,204
-5% -$77.3K
NEE.PRP
293
DELISTED
NEXTERA ENERGY INC EQUITY UNIT
NEE.PRP
$1.4M 0.04%
25,360
-3,000
-11% -$170K
T icon
294
AT&T
T
$160B
$1.38M 0.04%
51,366
-3,840
-7% -$99.2K
VA
295
DELISTED
Virgin America Inc.
VA
$1.37M 0.03%
50,000
+35,000
+233% +$1.01M
THRM icon
296
Gentherm
THRM
$1.32B
$1.37M 0.03%
25,000
-10,000
-29% -$530K
MODN
297
DELISTED
MODEL N, INC.
MODN
$1.37M 0.03%
115,000
+90,000
+360% +$1.07M
TXN icon
298
Texas Instruments
TXN
$259B
$1.35M 0.03%
26,300
– –
ALK icon
299
Alaska Air
ALK
$5.86B
$1.29M 0.03%
20,000
+13,000
+186% +$838K
F icon
300
Ford
F
$56.8B
$1.26M 0.03%
84,000
-36,900
-31% -$572K
10 11
12
13 14

Similar funds

DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
NC
NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BSA
Braun Stacey Associates New York $3.01B AUM 47.79% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
SGI
Swan Global Investments Durango, Colorado $3B AUM 15.66% 1-Year Est. Return

Palisade Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Palisade Capital Management held 559 positions worth $3.93B, down 1.2% from $3.98B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Palisade Capital Management withdrew a net $550M in Q2 2015, closing 35 positions and reducing 176 holdings. Its most notable exit was ACTAVIS PLC Pfd Conv Ser A (Irl), an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Palisade Capital Management opened a new position in Allergan plc worth $23.7M.

  • Palisade Capital Management's largest Q2 2015 buy was Allergan plc: 22,729 shares worth $23.7M.
  • Palisade Capital Management added most to Burlington in Q2 2015, an estimated $15.4M increase.
  • Palisade Capital Management's biggest Q2 2015 reduction was HCC INSURANCES HOLDINGS INC, cutting an estimated $19.6M.
  • Palisade Capital Management fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $20.8M.
  • Palisade Capital Management's ten largest holdings make up 10% of its $3.93B portfolio in Q2 2015.
  • Palisade Capital Management opened 64 new positions and closed 35 in Q2 2015.
  • Palisade Capital Management's portfolio value fell 1.2% quarter-over-quarter to $3.93B.

Based on Palisade Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.